These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34220965)

  • 1. PER1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Ovarian Cancer.
    Chen M; Zhang L; Liu X; Ma Z; Lv L
    Front Genet; 2021; 12():697471. PubMed ID: 34220965
    [No Abstract]   [Full Text] [Related]  

  • 2. MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer.
    Wu Z; Wang Y; Li J; Wang H; Tuo X; Zheng J
    Front Genet; 2022; 13():864578. PubMed ID: 35664337
    [No Abstract]   [Full Text] [Related]  

  • 3. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc Finger E-Box Binding Homeobox 2 as a Prognostic Biomarker in Various Cancers and Its Correlation with Infiltrating Immune Cells in Ovarian Cancer.
    Kim HR; Seo CW; Han SJ; Lee JH; Kim J
    Curr Issues Mol Biol; 2022 Mar; 44(3):1203-1214. PubMed ID: 35723302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of PPL expression in ovarian cancer.
    Hua T; Zhao BB; Fan SB; Zhao CF; Kong YH; Tian RQ; Zhang BY
    Discov Oncol; 2022 May; 13(1):35. PubMed ID: 35612641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.
    Yu L; Ding Y; Wan T; Deng T; Huang H; Liu J
    Front Immunol; 2021; 12():768115. PubMed ID: 34966389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Hou W; Kong L; Hou Z; Ji H
    BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
    World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ncRNA-mediated low expression of P2RY14 correlates with poor prognosis and tumor immune infiltration in ovarian carcinoma.
    Shu C; Liu L; Chen X; Xue J; Fei J; Wang J; Yang X; Peng Q; Yuan H
    Ann Transl Med; 2023 Jan; 11(1):10. PubMed ID: 36760244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
    Yu Z; Cheng L; Liu X; Zhang L; Cao H
    Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
    [No Abstract]   [Full Text] [Related]  

  • 14. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
    Zhu H; Wang G; Zhu H; Xu A
    BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer.
    Gao W; Liu D; Sun H; Shao Z; Shi P; Li T; Yin S; Zhu T
    BMC Cancer; 2022 Dec; 22(1):1367. PubMed ID: 36585688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD.
    Wang Z; Tian Z; Song X; Zhang J
    BMC Immunol; 2022 Jan; 23(1):1. PubMed ID: 34998385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RTP4 facilitating ovarian cancer by bioinformatics analysis and experimental validation.
    Fang C; Han W; Tang C; Shen J; Ni B
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; ():. PubMed ID: 39249504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 19. TIMELESS Promotes Tumor Progression by Enhancing Macrophages Recruitment in Ovarian Cancer.
    Xing X; Gu F; Hua L; Cui X; Li D; Wu Z; Zhang R
    Front Oncol; 2021; 11():732058. PubMed ID: 34490127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
    Wu Q; Yin G; Lei J; Tian J; Lan A; Liu S
    Front Mol Biosci; 2020; 7():599110. PubMed ID: 33363208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.